LEAWOOD, Kan. (AP) _ Aratana Therapeutics Inc. (PETX) on Wednesday reported a loss of $6.8 million in its first quarter.
On a per-share basis, the Leawood, Kansas-based company said it had a loss of 14 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The developer of pet medications posted revenue of $7.4 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $7 million.
In the final minutes of trading on Wednesday, the company's shares hit $4.65. A year ago, they were trading at $5.35.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PETX at https://www.zacks.com/ap/PETX